Functional evaluation of novel variants of B4GALNT1 in a patient with hereditary spastic paraplegia and the general population

被引:1
|
作者
Inamori, Kei-ichiro [1 ]
Nakamura, Katsuya [2 ,3 ]
Shishido, Fumi [4 ]
Hsu, Jia-Chen [1 ]
Nagafuku, Masakazu [1 ]
Nitta, Takahiro [1 ,5 ,6 ]
Ikeda, Junji [2 ]
Yoshimura, Hidekane [7 ]
Kodaira, Minori [2 ]
Tsuchida, Naomi [8 ,9 ]
Matsumoto, Naomichi [8 ]
Uemura, Satoshi [10 ]
Ohno, Shiho [11 ]
Manabe, Noriyoshi [11 ]
Yamaguchi, Yoshiki [11 ]
Togayachi, Akira [12 ]
Aoki-Kinoshita, Kiyoko F. [12 ]
Nishihara, Shoko [12 ]
Furukawa, Jun-ichi [13 ]
Kaname, Tadashi [14 ]
Nakamura, Masahiko [15 ]
Shimohata, Takayoshi [16 ]
Tadaka, Shu [17 ]
Shirota, Matsuyuki [17 ]
Kinoshita, Kengo [17 ]
Nakamura, Yutaka [4 ]
Ohno, Isao [4 ]
Sekijima, Yoshiki [2 ]
Inokuchi, Jin-ichi [18 ]
机构
[1] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Glycopathol, Sendai, Japan
[2] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Japan
[3] Shinshu Univ Hosp, Ctr Med Genet, Matsumoto, Japan
[4] Tohoku Med & Pharmaceut Univ, Fac Med, Ctr Med Educ, Sendai, Japan
[5] Juntendo Univ, Fac Pharm, Lab Bioregulatory Clin Phamacol, Urayasu, Japan
[6] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Urayasu, Japan
[7] Shinshu Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Matsumoto, Japan
[8] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Japan
[9] Yokohama City Univ Med, Dept Rare Dis Genom, Yokohama, Japan
[10] Tohoku Med & Pharmaceut Univ, Fac Med, Div Med Biochem, Sendai, Japan
[11] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Struct Glycobiol, Sendai, Japan
[12] Soka Univ, Glycan & Life Syst Integrat Ctr GaLSIC, Hachioji, Japan
[13] Nagoya Univ, Inst Glycocore Res iGCORE, Nagoya, Japan
[14] Natl Ctr Child Hlth & Dev, Dept Genome Med, Tokyo, Japan
[15] Matsumoto City Hosp, Dept Neurosurg, Matsumoto, Japan
[16] Gifu Univ, Grad Sch Med, Dept Neurol, Gifu, Japan
[17] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Japan
[18] Osaka Univ, Forefront Res Ctr, Grad Sch Sci, Toyonaka, Japan
关键词
hereditary spastic paraplegia; gangliosides; B4GALNT1; GM2/GD2; synthase; glycosyltransferase; missense variant; MYELIN-ASSOCIATED GLYCOPROTEIN; EXPRESSION CLONING; COMPLEX GANGLIOSIDES; SYNTHASE; MICE; CDNA; SPECIFICITY; DEFICIENT; LIGANDS; BIOLOGY;
D O I
10.3389/fnins.2024.1437668
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Hereditary spastic paraplegia (HSP) is a heterogeneous group of neurological disorders that are characterized by progressive spasticity and weakness in the lower limbs. SPG26 is a complicated form of HSP, which includes not only weakness in the lower limbs, but also cognitive impairment, developmental delay, cerebellar ataxia, dysarthria, and peripheral neuropathy, and is caused by biallelic mutations in the B4GALNT1 (beta-1,4-N-acetylgalactosaminyltransferase 1) gene. The B4GALNT1 gene encodes ganglioside GM2/GD2 synthase (GM2S), which catalyzes the transfer of N-acetylgalactosamine to lactosylceramide, GM3, and GD3 to generate GA2, GM2, and GD2, respectively. The present study attempted to characterize a novel B4GALNT1 variant (NM_001478.5:c.937G>A p.Asp313Asn) detected in a patient with progressive multi-system neurodegeneration as well as deleterious variants found in the general population in Japan. Peripheral blood T cells from our patient lacked the ability for activation-induced ganglioside expression assessed by cell surface cholera toxin binding. Structural predictions suggested that the amino acid substitution, p.Asp313Asn, impaired binding to the donor substrate UDP-GalNAc. An in vitro enzyme assay demonstrated that the variant protein did not exhibit GM2S activity, leading to the diagnosis of HSP26. This is the first case diagnosed with SPG26 in Japan. We then extracted 10 novel missense variants of B4GALNT1 from the whole-genome reference panel jMorp (8.3KJPN) of the Tohoku medical megabank organization, which were predicted to be deleterious by Polyphen-2 and SIFT programs. We performed a functional evaluation of these variants and demonstrated that many showed perturbed subcellular localization. Five of these variants exhibited no or significantly decreased GM2S activity with less than 10% activity of the wild-type protein, indicating that they are carrier variants for HSP26. These results provide the basis for molecular analyses of B4GALNT1 variants present in the Japanese population and will help improve the molecular diagnosis of patients suspected of having HSP.
引用
收藏
页数:12
相关论文
共 38 条
  • [21] Hereditary spastic paraplegia associated with a novel homozygous intronic noncanonical splice site variant in the AP4B1 gene
    Gomez-Gonzalez, Clara
    Pizarro-Sanchez, Cristina
    Rodriguez-Antolin, Carlos
    Pascual-Pascual, Ignacio
    Garcia-Romero, Mar
    Rodriguez-Jimenez, Carmen
    de Sancho-Martin, Ruben
    del Pozo-Mate, Angela
    Solis-Lopez, Mario
    Castro, Carmen Prior-de
    Torres, Rosa J.
    ANNALS OF HUMAN GENETICS, 2022, 86 (03) : 109 - 118
  • [22] Novel pathogenic variant of the SPAST gene (c.1413+4A>G) in a patient with hereditary spastic paraplegia
    Park, H. -M.
    Yang, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 885 - 885
  • [23] A novel frameshift DDHD1 mutation in a patient with hereditary spastic paraplegia type 28: Case report and review of the literature
    Pinheiro, Rita Goncalo
    Rato, Miguel Leal
    Silva, Claudia Santos
    Soares, Marta P.
    Carvalho, Vanessa
    Guedes, Leonor Correia
    PARKINSONISM & RELATED DISORDERS, 2024, 118
  • [24] AP4B1-associated hereditary spastic paraplegia: Expansion of clinico-genetic phenotype and geographic range
    Salayev, Kamran
    Rocca, Clarissa
    Kaiyrzhanov, Rauan
    Guliyeva, Ulviyya
    Guliyeva, Sughra
    Mursalova, Aytan
    Rahman, Fatima
    Anwar, Najwa
    Zafar, Faisal
    Jan, Farida
    Rana, Nuzhat
    Maqbool, Shazia
    Efthymiou, Stephanie
    Houlden, Henry
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2022, 65 (11)
  • [25] Mutation in the AP4B1 gene cause hereditary spastic paraplegia type 47 (SPG47)
    Peter Bauer
    Esther Leshinsky-Silver
    Lubov Blumkin
    Nina Schlipf
    Christopher Schröder
    Julia Schicks
    Dorit Lev
    Olaf Riess
    Tally Lerman-Sagie
    Ludger Schöls
    neurogenetics, 2012, 13 : 73 - 76
  • [26] Mutation in the AP4B1 gene cause hereditary spastic paraplegia type 47 (SPG47)
    Bauer, Peter
    Leshinsky-Silver, Esther
    Blumkin, Lubov
    Schlipf, Nina
    Schroeder, Christopher
    Schicks, Julia
    Lev, Dorit
    Riess, Olaf
    Lerman-Sagie, Tally
    Schoels, Ludger
    NEUROGENETICS, 2012, 13 (01) : 73 - 76
  • [27] CYP7B1: novel mutations and magnetic resonance spectroscopy abnormalities in hereditary spastic paraplegia type 5A
    Roos, P.
    Svenstrup, K.
    Danielsen, E. R.
    Thomsen, C.
    Nielsen, J. E.
    ACTA NEUROLOGICA SCANDINAVICA, 2014, 129 (05): : 330 - 334
  • [28] Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47
    Wiseman, Jessica P.
    Scarrott, Joseph M.
    Alves-Cruzeiro, Joao
    Saffari, Afshin
    Boger, Cedric
    Karyka, Evangelia
    Dawes, Emily
    Davies, Alexandra K.
    Marchi, Paolo M.
    Graves, Emily
    Fernandes, Fiona
    Yang, Zih-Liang
    Coldicott, Ian
    Hirst, Jennifer
    Webster, Christopher P.
    Highley, J. Robin
    Hackett, Neil
    Angyal, Adrienn
    de Silva, Thushan
    Higginbottom, Adrian
    Shaw, Pamela J.
    Ferraiuolo, Laura
    Ebrahimi-Fakhari, Darius
    Azzouz, Mimoun
    EMBO MOLECULAR MEDICINE, 2024, 16 (11) : 2882 - 2917
  • [29] Novel compound heterozygous variants in ALDH18A1 gene: expanding knowledge on autosomal recessive spastic paraplegia 9B
    Cali, Silvia
    Capra, Valeria
    Striano, Pasquale
    Vari, Maria Stella
    Madia, Francesca
    Henzen, Edoardo
    Faravelli, Francesca
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1485 - 1485
  • [30] AP4B1-associated hereditary spastic paraplegia: expansion of phenotypic spectrum related to homozygous p.Thr387fs variant
    Krzysztof Szczałuba
    Hanna Mierzewska
    Robert Śmigiel
    Joanna Kosińska
    Agnieszka Koppolu
    Anna Biernacka
    Piotr Stawiński
    Agnieszka Pollak
    Małgorzata Rydzanicz
    Rafał Płoski
    Journal of Applied Genetics, 2020, 61 : 213 - 218